Skip to main content
OpenTrials
Completed

NCT Number: NCT04833738

Hyaluronic Acid, Corticosteroid and Electrotherapy in Subacromial Impingement Syndrome

Background: Electrotherapy, corticosteroid, and hyaluronic acid have been used to treat subacromial impingement syndrome. However, we need to compare treatment options to provide the optimal results. This study aims to compare the effect of hyaluronic acid, corticosteroid, and electrotherapy in subacromial impingement syndrome.

Design: Ninety five patients were randomised into three equal groups according to treatment types. Hyaluronic acid (20 mg/2ml, three times one week apart) or corticosteroid (triamcinolone acetonide, 40 mg/ml, single dose) treatments were applied as subacromial injections. Electrotherapy consisted of 14 sessions TENS (20 min.), hotpack (20 min.) and ultrasound (1.5watt/cm2, 1 MHz, 6 min.). Patients were evaluated before treatment, one and four weeks post end of treatment. Visual Analogue Scale (VAS), range of motion (ROM), and Shoulder Disability Questionnaire (SDQ) were used as outcome measures.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Subacromial Impingement Arthralgia Joint Diseases Musculoskeletal Diseases Neurologic Manifestations Pain Pain, Shoulder Pathological Conditions, Signs and Symptoms Shoulder Impingement Syndrome Shoulder Injuries Shoulder Pain Signs and Symptoms Wounds and Injuries

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The diagnosis of subacromial impingement syndrome

Exclusion criteria

  • Patients aged <20 or >50 years or who have the following medical conditions were excluded: physical therapy or injection in the past 6 months, shoulder instability, acute trauma, adhesive capsulitis, psychiatric illness, diabetes mellitus, malignancy.

Treatment and study plan

Hyaluronic acid

Drug

Corticosteroids Triamcinolone Acetonide

Drug

triamcinolone acetonide, 40 mg/ml, single dose

electrotherapy

Other

electrotherapy

Primary outcomes

  1. Visual Analogue Scale

    Time frame: 1 min.

    Higher scores represent higher level of shoulder pain.

  2. range of motion

    Time frame: 5 min.

    Higher scores represent lower level of shoulder function.

  3. Shoulder Disability Questionnaire

    Time frame: 15 min

    Higher scores represent higher level of shoulder pain.

Sponsors and collaborators

Lead sponsor

Şeyhmus KAPLAN

Other

Registry information

Official study title

Subakromiyal sıkışma Sendromunda Hyaluronik Asit, Kortikosteroid ve Elektroterapi

Important dates

Study start
2013
Primary completion
2013
Study completion
2014
First posted
Apr 6, 2021
Registry last updated
Apr 6, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.